MONICA VALERIO: Open Payments
NPI 1679991723 · BURGETTSTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,406 in 74 payments from 16 companies in 2025. Trend: 2023 $1,872 · 2024 $1,235 · 2025 $1,406
Food & beverage: $1,406
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 17 | $294 |
| Corcept Therapeutics | 10 | $163 |
| Viatris Specialty LLC | 7 | $130 |
| Amgen Inc. | 7 | $121 |
| Novo Nordisk Inc | 5 | $87 |
| Lundbeck LLC | 4 | $85 |
| Avadel CNS Pharmaceuticals, LLC | 3 | $80 |
| Exact Sciences Corporation | 4 | $74 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $70 |
| BridgeBio Pharma, Inc. | 3 | $65 |
Products named: Korlym, FARXIGA, BRILINTA, YUPELRI, REPATHA, REXULTI, LUMRYZ, LifeVest.
Industry payments across PA — which companies pay providers there.
